Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascaline Boudou-Rouquette

Showing results (21-30 of 122) with videos related to

Pageof 13
Sort By:
Investigational New Drugs|May 27, 2011
Safety of bevacizumab 7.5 mg/kg infusion over 10 minutes in NSCLC patientsOlivier Mir, Jérôme Alexandre, Romain Coriat, et al.
Expert Opinion on Drug Metabolism & Toxicology|August 25, 2016
Clinical pharmacology, drug-drug interactions and safety of pazopanib: a reviewPascaline Boudou-Rouquette, Camille Tlemsani, Benoit Blanchet, et al.
Investigational New Drugs|November 1, 2011
Sorafenib exposure decreases over time in patients with hepatocellular carcinomaJennifer Arrondeau, Olivier Mir, Pascaline Boudou-Rouquette, et al.
Cancer Chemotherapy and Pharmacology|October 1, 2015
Risk factors for pegylated liposomal doxorubicin-induced palmar-plantar erythrodysesthesia over time: assessment of monocyte count and baseline clinical parametersZahra Ajgal, Nicolas Chapuis, George Emile, et al.
Anti-Cancer Drugs|June 16, 2012
Feasibility of gemcitabine and oxaliplatin in patients with advanced biliary tract carcinoma and a performance status of 2Olivier Mir, Romain Coriat, Marion Dhooge, et al.
Age and Ageing|January 3, 2026
Reliability of the cumulative illness rating scale for geriatrics for assessing multimorbidity in older patients with cancer: results from the ELCAPA cohortMarc A Benderra, Philippe Caillet, Amélie Aregui, et al.
Medical Oncology (Northwood, London, England)|March 20, 2012
Gemcitabine and oxaliplatin as second-line treatment in patients with hepatocellular carcinoma pre-treated with sorafenibOlivier Mir, Romain Coriat, Pascaline Boudou-Rouquette, et al.
Bulletin Du Cancer|August 7, 2018
[Integrated podiatrist care for prostate cancer patients treated with docetaxel: Feasibility and results]Hedi Chabanol, Olivier Huillard, Lucie Prin, et al.
European Journal of Radiology|August 9, 2024
Performance of AI for preoperative CT assessment of lung metastases: Retrospective analysis of 167 patientsGiorgio Maria Masci, Guillaume Chassagnon, Marco Alifano, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 20, 2016
A Real-Life Experience of Bevacizumab in Elderly Women With Advanced Ovarian CarcinomaGuillaume Beinse, George Emile, Anatole Cessot, et al.
Pageof 13

Showing results (21-30 of 122) with videos related to

Sort By:
Pageof 13
Investigational New Drugs|May 27, 2011
Safety of bevacizumab 7.5 mg/kg infusion over 10 minutes in NSCLC patientsOlivier Mir, Jérôme Alexandre, Romain Coriat, et al.
Expert Opinion on Drug Metabolism & Toxicology|August 25, 2016
Clinical pharmacology, drug-drug interactions and safety of pazopanib: a reviewPascaline Boudou-Rouquette, Camille Tlemsani, Benoit Blanchet, et al.
Investigational New Drugs|November 1, 2011
Sorafenib exposure decreases over time in patients with hepatocellular carcinomaJennifer Arrondeau, Olivier Mir, Pascaline Boudou-Rouquette, et al.
Cancer Chemotherapy and Pharmacology|October 1, 2015
Risk factors for pegylated liposomal doxorubicin-induced palmar-plantar erythrodysesthesia over time: assessment of monocyte count and baseline clinical parametersZahra Ajgal, Nicolas Chapuis, George Emile, et al.
Anti-Cancer Drugs|June 16, 2012
Feasibility of gemcitabine and oxaliplatin in patients with advanced biliary tract carcinoma and a performance status of 2Olivier Mir, Romain Coriat, Marion Dhooge, et al.
Age and Ageing|January 3, 2026
Reliability of the cumulative illness rating scale for geriatrics for assessing multimorbidity in older patients with cancer: results from the ELCAPA cohortMarc A Benderra, Philippe Caillet, Amélie Aregui, et al.
Medical Oncology (Northwood, London, England)|March 20, 2012
Gemcitabine and oxaliplatin as second-line treatment in patients with hepatocellular carcinoma pre-treated with sorafenibOlivier Mir, Romain Coriat, Pascaline Boudou-Rouquette, et al.
Bulletin Du Cancer|August 7, 2018
[Integrated podiatrist care for prostate cancer patients treated with docetaxel: Feasibility and results]Hedi Chabanol, Olivier Huillard, Lucie Prin, et al.
European Journal of Radiology|August 9, 2024
Performance of AI for preoperative CT assessment of lung metastases: Retrospective analysis of 167 patientsGiorgio Maria Masci, Guillaume Chassagnon, Marco Alifano, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 20, 2016
A Real-Life Experience of Bevacizumab in Elderly Women With Advanced Ovarian CarcinomaGuillaume Beinse, George Emile, Anatole Cessot, et al.
Pageof 13